top of page
Nelson Advisors > European Healthcare Technology Investment Banking


Nelson Advisors: How does the UK HealthTech, MedTech, Health AI markets compare to the European HealthTech, MedTech, Health AI markets?
The UK is Europe's largest single market for HealthTech, MedTech and Health AI capital, but most of its 2026 lead comes from one company. Strip out Isomorphic Labs and the UK looks like what it has been for a decade: the biggest country in a continent that still lacks growth capital, quick procurement and public-market exits.
Nelson Advisors
5 hours ago


Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 20th November 2026
European HealthTech this week (November 16th–20th, 2026) is anchored by MEDICA 2026 in Düsseldorf, several notable early-stage AI and biotech financings, and ongoing EU regulatory implementation across digital health and pharmaceuticals.
Nelson Advisors
12 hours ago


Nelson Advisors: Europe's Next Three Big HealthTech, Health AI and MedTech Opportunities. Where Founders and Investors Should Spend the Next 12 Months
European healthtech is short of capital and long on deadlines, and that combination is where the next returns will come from. The three biggest opportunities for the next 12 months are clinical AI that goes beyond the scribe, the data plumbing the European Health Data Space now makes compulsory, and a medtech market that Brussels is finally trying to reopen.
Nelson Advisors
1 day ago


Nelson Advisors: Google Cloud Gemini for Healthcare - Architecture, Capabilities, Economics and Market Assessment
Google Cloud unveiled Gemini for Healthcare on 10th November 2026 as a U.S. preview for Gemini Enterprise Standard and Gemini Enterprise Plus customers, introducing an agentic orchestration platform engineered to unify clinical, financial, and administrative workflows across hospitals, care providers, and health insurers. Extending Google's universal Gemini agent, the platform replaces single-turn chatbot interactions with multi-step task execution across existing electronic
Nelson Advisors
2 days ago


Nelson Advisors: Commure Acquires Elaborate to Automate the Post Visit Clinical Inbox
On November 16th, 2026, healthcare AI company Commure announced the acquisition of Elaborate, a New York-based clinical intelligence startup specialising in Electronic Health Record (EHR) inbox automation. Financial terms of the transaction were not disclosed. The deal embeds Elaborate's protocol-driven messaging and laboratory-contextualisation software directly into Commure's broader platform, extending a product suite that already spans patient intake, call center agents,
Nelson Advisors
3 days ago


Nelson Advisors: 10 Key Issues Killing European HealthTech, MedTech and Health AI Deals in the Current Market
Our article below sets out the ten issues that most often kill European healthtech, medtech and health AI deals today. None is new on its own. What is new is how many of them now turn up in the same transaction. Each section ends with what a seller can do about it, because most of these deal killers are visible, and fixable, long before a buyer finds them.
Nelson Advisors
4 days ago


Founder Bankers: Why Nelson Advisors Leads Europe's Lower to Mid-Market HealthTech, MedTech and Health AI M&A
Selling a healthcare technology company is the most consequential transaction most founders will ever make. It is also, for most of them, the first. Years of product decisions, regulatory submissions, hospital pilots and difficult funding rounds are compressed into a process that lasts a few months and is decided by a handful of conversations. In that process the founder is usually the least experienced person in the room. The acquirer's corporate development team has done th
Nelson Advisors
5 days ago


Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 13th November 2026
During the second week of November 2026 (covering Nov 6th–13th), major developments across European HealthTech and MedTech centred on UK public-sector digital infrastructure, regulatory shifts, early-stage capital trends, and major industry summits.
Nelson Advisors
Nov 13


Nelson Advisors: The ring wants to be your doctor: analysing Oura's $625M Counsel Health acquisition
Oura has spent a decade telling people what their bodies are doing. On Tuesday it paid $625 million for the ability to do something about it. The smart-ring maker has agreed to buy Counsel Health, an AI-native virtual primary care company, in an all-cash deal expected to close before the end of 2026. Counsel pairs a chat-based medical AI with its own board-certified physicians, who can join a conversation within minutes to diagnose, prescribe and refer. The service already si
Nelson Advisors
Nov 11


Nelson Advisors: The Liquidity Paradox - Venture Capital Concentration, Valuation Resets and the Structural Exit Bottleneck in Digital Health
The primary bottleneck confronting digital health investors is no longer technical feasibility or software development velocity, but enterprise procurement friction, health system architectural integration, and the structural realisation of Distributed to Paid In capital (DPI).
Nelson Advisors
Nov 10


Nelson Advisors: Is Oracle Cerner for sale? If so, who are the most likely acquirers in the current climate?
Oracle Health, the business built on Cerner, is not officially for sale. Oracle has announced no process, and every public statement since January says it is doubling down. Yet the question refuses to die, because Oracle's balance sheet keeps asking it.
Nelson Advisors
Nov 10


Nelson Advisors: The New World of Earn-Outs in European HealthTech, MedTech and Health AI
The earn-out used to be the clause everyone hoped to delete before signing. In European HealthTech, MedTech and Health AI it has quietly become the deal itself. A founder selling a Series B diagnostics company in Munich, a PE-backed buyer consolidating radiology AI across the Nordics, a US strategic picking up a UK remote-monitoring business: in each case, a meaningful slice of the price, often 20 to 50 per cent, now sits behind a set of post-completion conditions.
Nelson Advisors
Nov 9


Nelson Advisors: Strategic Analysis of Ellipsis Health's Acquisition of Kouper Health and the Platform Consolidation Wave
In November 2026, San Francisco-based voice artificial intelligence developer Ellipsis Health completed the acquisition of New York-based care navigation startup Kouper Health for an undisclosed valuation. The transaction represents an operational transition within digital health: the migration of conversational voice AI from standalone acoustic observation into closed-loop, deterministic execution across clinical workflows.
Nelson Advisors
Nov 7


Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 6th November 2026
The European HealthTech and MedTech ecosystem has seen notable moves across clinical AI deployment, funding, and major ecosystem gatherings:
Several major developments have emerged across the European Health AI ecosystem this week, spanning new early-stage funding, clinical AI validation, market consolidation analysis, and regulatory policy milestones:
Nelson Advisors
Nov 6


Nelson Advisors: Fertifa Acquires Tuune: What the Deal Means for Workplace Women's Health
Fertifa, the London healthtech run by venture capitalist Eileen Burbidge, has agreed to buy Tuune, a women's health company whose regulated clinical software helps clinicians deliver personalised hormonal care. The deal, first reported by Sky News, is expected to be announced this week. Its value is not being disclosed.
Nelson Advisors
Nov 5
Add a title here. Make it bold and impactful. Click to edit.
Nelson Advisors specialise in Mergers and Acquisitions for European HealthTech, MedTech, Digital Health, Healthcare IT, Healthcare AI companies in the Lower to Mid Market ranging from $25M to $250M EV.
bottom of page